KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Asset Writedowns and Impairment: 2009-2025

Historic Asset Writedowns and Impairment for Bausch Health Companies (BHC) over the last 11 years, with Sep 2025 value amounting to $1.0 million.

  • Bausch Health Companies' Asset Writedowns and Impairment was N/A to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.0 million, marking a year-over-year change of. This contributed to the annual value of $29.0 million for FY2024, which is 46.30% down from last year.
  • Bausch Health Companies' Asset Writedowns and Impairment amounted to $1.0 million in Q3 2025, which was down 95.65% from $23.0 million recorded in Q4 2024.
  • Bausch Health Companies' 5-year Asset Writedowns and Impairment high stood at $148.0 million for Q1 2021, and its period low was $1.0 million during Q3 2022.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $5.0 million (2024), whereas its average is $12.0 million.
  • In the last 5 years, Bausch Health Companies' Asset Writedowns and Impairment skyrocketed by 4,600.00% in 2021 and then crashed by 94.59% in 2022.
  • Quarterly analysis of 5 years shows Bausch Health Companies' Asset Writedowns and Impairment stood at $21.0 million in 2021, then tumbled by 94.44% to $1.0 million in 2022, then spiked by 300.00% to $4.0 million in 2023, then slumped by 86.49% to $23.0 million in 2024, then reached $1.0 million in 2025.
  • Its Asset Writedowns and Impairment was $1.0 million in Q3 2025, compared to $23.0 million in Q4 2024 and $5.0 million in Q2 2024.